Wellness Clinics and White House Gatekeepers Push Peptide Cures
July 24, 2026
From Australian longevity startups to FDA expert panels and podcast networks, wellness clinics and political insiders are capitalizing on unapproved amino acid treatments like BPC-157. As regulatory guardrails erode under executive pressure from figures aligned with the MAHA agenda, commercial players and wellness influencers are transforming speculative health claims into lucrative distribution channels.
-
BRIEF
How wellness clinics bend the rules to supply unapproved peptides and anti-ageing injections
YakobchukOlena/Getty Images Across Australia, “longevity” and “wellness” clinics, most of them online, sell injections that promise to slow ageing, build muscle, heal injuries and help you sleep. This week’s ABC 4 Corners described a doctor prescribing a “stack” of them after a short questionnaire a…
- all
-
BRIEF
America Is About to Go Over a Peptide Cliff
BPC-157 is rumored to heal almost anything: a sore shoulder, a bum knee, a pulled hamstring, ulcerative colitis. Maybe even traumatic brain injuries and multiple sclerosis, too. The drug—part of a class called peptides—has been around for decades. But it has recently experienced a surge in popularit…
-
BRIEF
An FDA Panel Just Endorsed These Unproven Peptides
Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA's bulk list, including the “Wolverine stack” touted by Joe Rogan and other influencers.
-
BRIEF
The Great Peptide Cash Grab Has Begun
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
-
BRIEF
The White House’s MAHA Gatekeeper
Sign up for Inside the Trump Presidency, a newsletter featuring coverage of the second Trump term. The world’s most popular podcaster, Joe Rogan, reached out privately in April to the world’s most powerful man, Donald Trump, to discuss the healing power of ibogaine, a psychedelic made from the root…
-
BRIEF
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
- geopolitics
- structural power